Introduction
The founders of the Clinical Trial Guide discuss the challenges of recruiting patients into studies of investigational treatments. They explore how pharmaceutical companies and regulators have increased their focus on diversity and inclusion in studies so trial participants better represent clinically relevant patient populations. Learn how trials are changing to enroll people whose genders, ethnicities, races, ages or disabilities have been traditionally underrepresented.